61 – 70 of 125
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma
- Contribution to journal › Article
-
Mark
Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial
- Contribution to journal › Article
-
Mark
Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study
- Contribution to journal › Article
-
Mark
Patterns of multiple myeloma during the past 5 decades: stable incidence rates for all age groups in the population but rapidly changing age distribution in the clinic.
- Contribution to journal › Article
-
Mark
Patterns of Improved Survival in Patients With Multiple Myeloma in the Twenty-First Century: A Population-Based Study.
- Contribution to journal › Article
-
Mark
Survival and Years of Life Lost in Different Age Cohorts of Patients With Multiple Myeloma.
- Contribution to journal › Article
-
Mark
Diagnostik och uppföljning av patienter med små M-komponenter. Med sikte på att undvika transformation till malign sjukdom.
- Contribution to journal › Scientific review
-
Mark
Immune-Related and Inflammatory Conditions and Risk of Lymphoplasmacytic Lymphoma or Waldenstrom Macroglobulinemia.
- Contribution to journal › Article
-
Mark
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management
- Contribution to journal › Scientific review
- 2009
-
Mark
Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: A population-based study
(2009) 14th Annual Meeting of the European-Hematology-Association In Haematologica-The Hematology Journal 94. p.0391-0391
- Contribution to journal › Published meeting abstract